Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantationReid W. Merryman, Philippe Armand, Caron A. Jacobson et al.|Blood Advances|2022Cited by 19
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular LymphomaReid W. Merryman, Heather A. Jacene, Laure Michaud et al.|HemaSphere|2023Cited by 11
Prognostic Value of Circulating Tumor DNA (ctDNA) in Autologous Stem Cell Graft and Post-Transplant Plasma Samples Among Patients with Diffuse Large B-Cell LymphomaReid W. Merryman, Philippe Armand, Robert Redd et al.|Blood|2020Cited by 9
Prognostic value of minimal residual disease among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantationEleanor Taranto, Reid W. Merryman, Robert Redd et al.|Leukemia & lymphoma/Leukemia and lymphoma|2022Cited by 6
Interim Positron Emission Tomography (iPET) Assessed Using Deauville Score for Patients with Follicular Lymphoma Receiving First-Line ChemoimmunotherapyReid W. Merryman, Heather A. Jacene, Gabriela Spilberg et al.|Blood|2020Cited by 1